Pgl-M 75 Capsule

产品概览

About Pgl-M 75

Pgl-M 75 is a medication containing the active ingredient Benfotiamine, classified as Thiamine analogue. Benfotiamine is a synthetic, fat-soluble, S-acyl derivative of thiamine that is approved in some countries as a medication or dietary supplement to treat diabetic sensorimotor polyneuropathy. Benfotiamine was developed in the late 1950s in Japan.

Key Benefits & Uses

• Used for: Benfotiamine is a synthetic, fat-soluble, S-acyl derivative of thiamine that is approved in some countries as a medication or dietary supplement to.
• Used for: Benfotiamine was developed in the late 1950s in Japan
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Benfotiamine, the active ingredient in Pgl-M 75, belongs to the Thiamine analogue class. Its clinical use follows the authorised labelling for Benfotiamine-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Pgl-M 75. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Pgl-M 75 for extended periods without medical advice.